ArticlePloS one2022

Therapeutic treatment with the anti-inflammatory drug candidate MW151 may partially reduce memory impairment and normalizes hippocampal metabolic markers in a mouse model of comorbid amyloid and vascular pathology.

David J Braun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.